Healthy men test new version of arthritis drug
NCT ID NCT06262477
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called BIIB800 against an approved drug, Actemra, in 300 healthy men. The goal was to see if the two drugs behave similarly in the body and are equally safe. Participants received a single injection and were monitored for side effects and drug levels.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fortrea Clinical Research Unit Inc.
Daytona Beach, Florida, 32117, United States
-
Fortrea Clinical Research Unit Inc.
Dallas, Texas, 75247, United States
-
Fortrea Clinical Research Unit Inc.
Madison, Wisconsin, 53704, United States
-
Fortrea Clinical Research Unit Inc.
Leeds, West Yorkshire, LS2 9LH, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?